Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP989993.RACQUmDbtGJYn4nRIajPGxuRo5Va1PZuLOlh4Ehup9_FY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP989993.RACQUmDbtGJYn4nRIajPGxuRo5Va1PZuLOlh4Ehup9_FY130_assertion type Assertion NP989993.RACQUmDbtGJYn4nRIajPGxuRo5Va1PZuLOlh4Ehup9_FY130_head.
- NP989993.RACQUmDbtGJYn4nRIajPGxuRo5Va1PZuLOlh4Ehup9_FY130_assertion wasGeneratedBy ECO_0000203 NP989993.RACQUmDbtGJYn4nRIajPGxuRo5Va1PZuLOlh4Ehup9_FY130_provenance.
- NP989993.RACQUmDbtGJYn4nRIajPGxuRo5Va1PZuLOlh4Ehup9_FY130_assertion wasDerivedFrom befree-20150227 NP989993.RACQUmDbtGJYn4nRIajPGxuRo5Va1PZuLOlh4Ehup9_FY130_provenance.
- NP989993.RACQUmDbtGJYn4nRIajPGxuRo5Va1PZuLOlh4Ehup9_FY130_assertion SIO_000772 24025407 NP989993.RACQUmDbtGJYn4nRIajPGxuRo5Va1PZuLOlh4Ehup9_FY130_provenance.
- NP989993.RACQUmDbtGJYn4nRIajPGxuRo5Va1PZuLOlh4Ehup9_FY130_assertion evidence source_evidence_literature NP989993.RACQUmDbtGJYn4nRIajPGxuRo5Va1PZuLOlh4Ehup9_FY130_provenance.
- NP989993.RACQUmDbtGJYn4nRIajPGxuRo5Va1PZuLOlh4Ehup9_FY130_assertion description "[Given the emergence of NANOG as a pro-carcinogenic protein in multiple cancers, these studies suggest that inhibition of LEPR may be a promising therapeutic approach to inhibit NANOG and thereby neutralize CSC functions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP989993.RACQUmDbtGJYn4nRIajPGxuRo5Va1PZuLOlh4Ehup9_FY130_provenance.